Prostaglandin F2 alpha receptor (PTGFR), a membrane receptor for prostaglandin F2 alpha, has been reported to be related to tumorigenesis and progression in endometrial adenocarcinoma. The gene discussed is PTGFR; the disease is endometrium adenocarcinoma.